Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colorectal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Tuberous Sclerosis 1 Thyroid Neoplasms 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphangioleiomyomatosis 1 Kidney Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 HER2-positive Breast Cancer 1 Glioma 1 Early Detection of Cancer 1 Breast Carcinoma In Situ 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

pembrolizumab 38 Blood Specimen Collection 38 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 17 Exercise 17 Carboplatin 17 Nivolumab 15 atezolizumab 14 Paclitaxel 14 Cisplatin 14 Drug Therapy 13 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 11 Trastuzumab 10 Pemetrexed 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Genetic Testing × Clear all

NCT06008392 2026-04-07

INTERCEPTioN

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡